Immunis, Inc

Immunis Inc. is a private, clinical-stage biotechnology company developing stem cell-derived secretome therapies to address age-related diseases and immune dysfunction. The secretome is the total set of factors secreted from a cell including proteins, lipids, growth factors, cytokines, and exosomes. A well-functioning immune system is necessary for our health and secretomes can refine immune cell responses, making them a promising therapeutic for autoimmune, neurodegenerative and age-related muscle wasting diseases (sarcopenia). Our investigational secretome, IMMUNA, includes a balance of all-natural, clinical-grade factors that benefit immune system development, modulation, and health. Immunis published pre-clinical data in GeroScience demonstrates that IMMUNA benefits muscle...

Sarcopenia,muscle atrophy,metabolism,cell therapy,secretome,human healthspan,muscle health,and obesity

Immunis, inc operates in the Biotechnology research industry.

Immunis, inc's revenue is 11m - 100m

Immunis, inc has 11 - 50 employees.